315 related articles for article (PubMed ID: 27794108)
1. FGF21 is a biomarker for mitochondrial translation and mtDNA maintenance disorders.
Lehtonen JM; Forsström S; Bottani E; Viscomi C; Baris OR; Isoniemi H; Höckerstedt K; Österlund P; Hurme M; Jylhävä J; Leppä S; Markkula R; Heliö T; Mombelli G; Uusimaa J; Laaksonen R; Laaksovirta H; Auranen M; Zeviani M; Smeitink J; Wiesner RJ; Nakada K; Isohanni P; Suomalainen A
Neurology; 2016 Nov; 87(22):2290-2299. PubMed ID: 27794108
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic value of serum biomarkers FGF21 and GDF15 compared to muscle sample in mitochondrial disease.
Lehtonen JM; Auranen M; Darin N; Sofou K; Bindoff L; Hikmat O; Uusimaa J; Vieira P; Tulinius M; Lönnqvist T; de Coo IF; Suomalainen A; Isohanni P
J Inherit Metab Dis; 2021 Mar; 44(2):469-480. PubMed ID: 32857451
[TBL] [Abstract][Full Text] [Related]
3. Successful Glycemic Control Decreases the Elevated Serum FGF21 Level without Affecting Normal Serum GDF15 Levels in a Patient with Mitochondrial Diabetes.
Murakami T; Ueba Y; Shinoto Y; Koga Y; Kaneda D; Hatoko T; Kato T; Yonemitsu S; Muro S; Oki S
Tohoku J Exp Med; 2016 Jun; 239(2):89-94. PubMed ID: 27212224
[TBL] [Abstract][Full Text] [Related]
4. Fibroblast growth factor 21 and grow differentiation factor 15 are sensitive biomarkers of mitochondrial diseases due to mitochondrial transfer-RNA mutations and mitochondrial DNA deletions.
Formichi P; Cardone N; Taglia I; Cardaioli E; Salvatore S; Gerfo AL; Simoncini C; Montano V; Siciliano G; Mancuso M; Malandrini A; Federico A; Dotti MT
Neurol Sci; 2020 Dec; 41(12):3653-3662. PubMed ID: 32504279
[TBL] [Abstract][Full Text] [Related]
5. FGF21 outperforms GDF15 as a diagnostic biomarker of mitochondrial disease in children.
Riley LG; Nafisinia M; Menezes MJ; Nambiar R; Williams A; Barnes EH; Selvanathan A; Lichkus K; Bratkovic D; Yaplito-Lee J; Bhattacharya K; Ellaway C; Kava M; Balasubramaniam S; Christodoulou J
Mol Genet Metab; 2022 Jan; 135(1):63-71. PubMed ID: 34991945
[TBL] [Abstract][Full Text] [Related]
6. FGF-21 as a biomarker for muscle-manifesting mitochondrial respiratory chain deficiencies: a diagnostic study.
Suomalainen A; Elo JM; Pietiläinen KH; Hakonen AH; Sevastianova K; Korpela M; Isohanni P; Marjavaara SK; Tyni T; Kiuru-Enari S; Pihko H; Darin N; Õunap K; Kluijtmans LA; Paetau A; Buzkova J; Bindoff LA; Annunen-Rasila J; Uusimaa J; Rissanen A; Yki-Järvinen H; Hirano M; Tulinius M; Smeitink J; Tyynismaa H
Lancet Neurol; 2011 Sep; 10(9):806-18. PubMed ID: 21820356
[TBL] [Abstract][Full Text] [Related]
7. A comparison of current serum biomarkers as diagnostic indicators of mitochondrial diseases.
Davis RL; Liang C; Sue CM
Neurology; 2016 May; 86(21):2010-5. PubMed ID: 27164684
[TBL] [Abstract][Full Text] [Related]
8. Circulating FGF21 and GDF15 as Biomarkers for Screening, Diagnosis, and Severity Assessment of Primary Mitochondrial Disorders in Children.
Li Y; Li S; Qiu Y; Zhou M; Chen M; Hu Y; Hong S; Jiang L; Guo Y
Front Pediatr; 2022; 10():851534. PubMed ID: 35498801
[TBL] [Abstract][Full Text] [Related]
9. Growth Differentiation Factor 15 Is a Novel Diagnostic Biomarker of Mitochondrial Diseases.
Ji X; Zhao L; Ji K; Zhao Y; Li W; Zhang R; Hou Y; Lu J; Yan C
Mol Neurobiol; 2017 Dec; 54(10):8110-8116. PubMed ID: 27889897
[TBL] [Abstract][Full Text] [Related]
10. Associations of FGF21 and GDF15 with mitochondrial dysfunction in children living with perinatally-acquired HIV: A cross-sectional evaluation of pediatric AIDS clinical trials group 219/219C.
Gojanovich GS; Jacobson DL; Broadwell C; Karalius B; Kirmse B; Geffner ME; Jao J; Van Dyke RB; McFarland EJ; Silio M; Crain M; Gerschenson M;
PLoS One; 2021; 16(12):e0261563. PubMed ID: 34972147
[TBL] [Abstract][Full Text] [Related]
11. Fibroblast Growth Factor 21 Drives Dynamics of Local and Systemic Stress Responses in Mitochondrial Myopathy with mtDNA Deletions.
Forsström S; Jackson CB; Carroll CJ; Kuronen M; Pirinen E; Pradhan S; Marmyleva A; Auranen M; Kleine IM; Khan NA; Roivainen A; Marjamäki P; Liljenbäck H; Wang L; Battersby BJ; Richter U; Velagapudi V; Nikkanen J; Euro L; Suomalainen A
Cell Metab; 2019 Dec; 30(6):1040-1054.e7. PubMed ID: 31523008
[TBL] [Abstract][Full Text] [Related]
12. Expanding and validating the biomarkers for mitochondrial diseases.
Maresca A; Del Dotto V; Romagnoli M; La Morgia C; Di Vito L; Capristo M; Valentino ML; Carelli V;
J Mol Med (Berl); 2020 Oct; 98(10):1467-1478. PubMed ID: 32851462
[TBL] [Abstract][Full Text] [Related]
13. Elevated FGF 21 in myotonic dystrophy type 1 and mitochondrial diseases.
Lovadi E; Csereklyei M; Merkli H; FüLöp K; Sebők Á; Karcagi V; Komoly S; Pál E
Muscle Nerve; 2017 Apr; 55(4):564-569. PubMed ID: 27489983
[TBL] [Abstract][Full Text] [Related]
14. Protein biomarkers GDF15 and FGF21 to differentiate mitochondrial hepatopathies from other pediatric liver diseases.
Van Hove JLK; Friederich MW; Strode DK; Van Hove RA; Miller KR; Sharma R; Shah H; Estrella J; Gabel L; Horslen S; Kohli R; Lovell MA; Miethke AG; Molleston JP; Romero R; Squires JE; Alonso EM; Guthery SL; Kamath BM; Loomes KM; Rosenthal P; Mysore KR; Cavallo LA; Valentino PL; Magee JC; Sundaram SS; Sokol RJ;
Hepatol Commun; 2024 Jan; 8(1):. PubMed ID: 38180987
[TBL] [Abstract][Full Text] [Related]
15. FGF21 in ataxia patients with spinocerebellar atrophy and mitochondrial disease.
Su SL; Wang WF; Wu SL; Wu HM; Chang JC; Huang CS; Cheng WL; Soong BW; Lee YC; Li JY; Kuo SJ; Chen M; Huang CN; Liu CS
Clin Chim Acta; 2012 Dec; 414():225-7. PubMed ID: 23031666
[TBL] [Abstract][Full Text] [Related]
16. GDF-15 Is Elevated in Children with Mitochondrial Diseases and Is Induced by Mitochondrial Dysfunction.
Montero R; Yubero D; Villarroya J; Henares D; Jou C; Rodríguez MA; Ramos F; Nascimento A; Ortez CI; Campistol J; Perez-Dueñas B; O'Callaghan M; Pineda M; Garcia-Cazorla A; Oferil JC; Montoya J; Ruiz-Pesini E; Emperador S; Meznaric M; Campderros L; Kalko SG; Villarroya F; Artuch R; Jimenez-Mallebrera C
PLoS One; 2016; 11(2):e0148709. PubMed ID: 26867126
[TBL] [Abstract][Full Text] [Related]
17. Serum FGF21 levels in adult m.3243A>G carriers: clinical implications.
Koene S; de Laat P; van Tienoven DH; Vriens D; Brandt AM; Sweep FC; Rodenburg RJ; Donders AR; Janssen MC; Smeitink JA
Neurology; 2014 Jul; 83(2):125-33. PubMed ID: 24907231
[TBL] [Abstract][Full Text] [Related]
18. The fibroblast growth factor 21 concentration in children with mitochondrial disease does not depend on the disease stage, but rather on the disease genotype.
Wesół-Kucharska D; Rokicki D; Greczan M; Kaczor M; Czekuć-Kryśkiewicz E; Piekutowska-Abramczuk D; Halat-Wolska P; Ciara E; Jaworski M; Jezela-Stanek A
Pediatr Endocrinol Diabetes Metab; 2022; 28(2):141-151. PubMed ID: 35620925
[TBL] [Abstract][Full Text] [Related]
19. Glucagon augments the secretion of FGF21 and GDF15 in MASLD by indirect mechanisms.
Richter MM; Kemp IM; Heebøll S; Winther-Sørensen M; Kjeldsen SAS; Jensen NJ; Nybing JD; Linden FH; Høgh-Schmidt E; Boesen MP; Madsbad S; Schiødt FV; Nørgaard K; Schmidt S; Gluud LL; Haugaard SB; Holst JJ; Nielsen S; Rungby J; Wewer Albrechtsen NJ
Metabolism; 2024 Jul; 156():155915. PubMed ID: 38631460
[TBL] [Abstract][Full Text] [Related]
20. A new diagnostic indication device of a biomarker growth differentiation factor 15 for mitochondrial diseases: From laboratory to automated inspection.
Koga Y; Povalko N; Inoue E; Ishii A; Fujii K; Fujii T; Murayama K; Mogami Y; Hata I; Ikawa M; Fukami K; Fukumoto Y; Nomura M; Ichikawa K; Yoshida K
J Inherit Metab Dis; 2021 Mar; 44(2):358-366. PubMed ID: 32965044
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]